766 Anxiety is a potential mediating factor in the insomnia-aggression association

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A298-A298
Author(s):  
Spencer Nielson ◽  
Joseph Dzierzewski ◽  
Daniel Kay

Abstract Introduction Several recent studies have found an association between insomnia and increased aggression. Aggression may increase arousal, thereby predisposing individuals to sleep difficulties. Conversely, insomnia may impair brain circuitry involved in aggression. Ultimately, the relationship between insomnia and aggression remains poorly understood and understudied. This study sought to explore this association in a sample of individuals with a wide range of insomnia symptom severity, stratified from minimal to moderately severe. Methods Participants’ (N=66) insomnia symptoms were assessed using the Insomnia Severity Index. Participants also completed daily sleep diaries for 7–21 days followed by an ambulatory polysomnography overnight sleep study to characterize participants’ sleep and to rule out organic sleep disorders. The evening of the overnight sleep study, participants completed the 34-item Buss-Perry Aggression Questionnaire (AQ). Pearson’s correlation coefficient was used to assess associations between insomnia, AQ total score, and the AQ subscale scores (i.e., physical aggression, verbal aggression, anger, hostility, indirect aggression). Multiple regression was utilized to determine whether aggression was associated with insomnia severity while adjusting for demographic features, depression symptoms (Patient Health Questionnaire-9) and trait anxiety (State-Trait Anxiety inventory). Results In bivariate analyses, insomnia severity was significantly correlated with the AQ total score and with the anger and hostility subscales of the AQ (r=0.297, p<0.05; r=0.266, p<0.05; r=0.321, p<0.05 respectively). When adjusting for the significant association between anxiety and insomnia in multiple regression analyses, anger and hostility were no longer significantly associated with insomnia severity(p>.05). Conclusion Our investigation suggests that the association between insomnia and aggression is most specific to anger and hostility but that these associations may be better explained by their shared associations with anxiety. Support (if any):

2018 ◽  
Vol 22 (3) ◽  
pp. 247-259
Author(s):  
William Vaughn McCall ◽  
Alan Letton ◽  
Jordan Lundeen ◽  
Doug Case ◽  
Francisco J. Cidral-Filho

Purpose The application of far-infrared energy to skin is expected to lead to vasodilatation of the skin surface, consequently warming the skin, and promoting sleep induction. The purpose of this paper was to test whether bedsheets impregnated with bioceramic far-infrared technology would improve the perception of sleep in a sample of healthy adults. Design/methodology/approach Twenty-nine adults consented to participate, randomizing 17 to the far-infrared bedsheets and 12 to the control bedsheets. Two of the control participants dropped out prior to randomization and prior to completing any assessments and therefore are excluded from the analyses. After baseline assessment, participants slept on their randomly assigned sheets for five weeks, followed by a one week “wash out”. Insomnia symptoms were assessed with the Insomnia Severity Index, depression symptoms with the Patient Health Questionnaire, “vigor” and “fatigue” with the Profile of Mood States, and napping behavior with daily sleep diaries. Findings During the period of randomization, the participants on the far-infrared sheets reported fewer insomnia symptoms and less napping. This advantage was lost during the wash out period. Originality/value Far-infrared technology produces benefits on reported sleep in healthy normal adults.


2009 ◽  
Vol 10 ◽  
pp. S20 ◽  
Author(s):  
L.S. Castro ◽  
D. Poyares ◽  
R. Santos-Silva ◽  
S.G. Conway ◽  
S. Tufik ◽  
...  

2020 ◽  
Author(s):  
ozlem arican ozluk ◽  
Berkay Ekici ◽  
mehdi zoghi ◽  
elif ilkay yüce ◽  
caglar ozmen ◽  
...  

Abstract Background: In this study, the anxiety levels and sleep qualities of cardiologists who continue to treat cardiac emergency patients in addition to their epidemic duties during the period when the COVID 19 pandemic was the most intense and the unknown was the most in our country. Methods: This cross-sectional study included 347 cardiologists throughout Turkey from April 17 to 20, 2020. The research was conducted by means of a confidential on-line survey. The research used the Turkish versions of the 7-item Generalized Anxiety Disorder Scale, 7-item Insomnia Severity Index and 9 –item Patient Health Questionnaire.Results : Of the total number of respondents, n= 193 (55.6 %) were aged 31 to 40 years and n= 84 ( 24.2%) were women. 79% of the participants were working in tertiary care centers where cardiac patients and covid patients were admitted and treated more. A considerable proportion of participants reported symptoms of anxiety (54.2 %), insomnia (44.1%), and depression (%71.1). Women cardiologist reported more severe degrees of all measurements of anxiety symptoms and depression symptoms than male cardiologists. Mean Generalized Anxiety Disorder scale scores among women vs male : 6.6 ± 3.5 vs 5.0 ± 4.3 ; p = 0.005 ; mean Insomnia Severity Index scores among women vs male doctors: 7.3±4.3 vs 6.9±4.6; P > 0.05; mean Impact of Event Scale–Revised scores among women vs male cardiologists : 8.0 ± 3.9 vs 6.8± 4.7; p = 0.02. Conclusions: In this survey, during this outbreak most of the cardiologists were found to be mentally challenged while continuing their profession. Especially the anxiety and depression symptoms of female doctor are higher than their male counterparts. The anxiety and stress disorder created by this pandemic may have serious consequences in the future, especially for physicians in intensive branches such as cardiology, who have to serve large patient groups in like low and middle-income countries. It should not be ignored that female doctors working in these branches are more sensitive to burnout syndrome.


2021 ◽  
Vol 2 ◽  
pp. 5
Author(s):  
Sadhna Verma ◽  
James Donovan ◽  
Surekha Bhat ◽  
Hari Tunuguntla ◽  
Renuka Tunuguntla ◽  
...  

Objectives: The COVID-19 pandemic has created significant psychological challenges globally. Evidence has been mounting of greater emotional distress and possible worsening of underlying psychiatric disorders, due to repercussions of COVID-19. In addition, the pandemic has created barriers to access for help, due to social distancing and travel restrictions. Thus, creating a major need for effective interventions that can be accessed safely from home and provide coping tools which can be learned and practiced while in isolation. An App based Yoga of Immortals (YOI) program is one such strategy to help cope with stressful situations. The objective of this study was to investigate if the YOI program can provide significant benefit for depressive and insomnia symptoms. Material and Methods: Participants in this study were asked to complete two brief online but well validated mental health screening tools before intervention. This was followed by a 7-week long YOI intervention. Following the intervention, participants were once again asked to complete the online validated questionnaires. The survey questionnaires included baseline demographic data and validated scales for measuring insomnia severity Insomnia severity Index (ISI) and levels of depression symptoms patient health questionnaire-8, (PHQ-8). All statistical analysis was performed using the Statistical Package for the Social Science. Results: SY YOI intervention of 7 weeks significantly improved the ISI scores as well as PHQ-8 scores in the study population (P < 0.0001 in all comparisons). Conclusion: YOI intervention is an effective intervention strategy for decreasing insomnia and depression symptoms, even during the pandemic.


2019 ◽  
pp. 47-53
Author(s):  
David L. Brody

Patients will get worse over time, not better, if they accumulate sleep deficit from chronic insomnia. The hierarchy for sleep is as follows: Best is good-quality natural sleep, second best is pharmacologically enhanced good-quality sleep, worst is insufficient or poor-quality sleep. The main tools are cognitive behavioral therapy for insomnia and pain control. Sleep medications such as Melatonin, zolpidem (Ambien), Eszopiclone (Lunesta), and trazodone are helpful and relatively safe for short-term use in concussion patients. Avoid whenever possible medications that can impair recovery and cognitive function, such as benzodiazepines, anticholinergics, and antipsychotics; avoid use of alcohol as a sleep aide. Consider using a quantitative tool such as the Insomnia Severity Index. If there are concerns, refer to a sleep medicine clinic for consultation and a formal sleep study; patients may not be reliable historians with regard to their sleep habits. Obstructive sleep apnea is very common in concussion patients.


SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A91-A91
Author(s):  
M A Clay ◽  
A Athey ◽  
J Charest ◽  
A Auerbach ◽  
R W Turner ◽  
...  

Abstract Introduction Collegiate student-athletes face challenges balancing academics and athletics, and getting an adequate amount of sleep is one factor that can assist in sustaining an elite level of play. Team-based sports may present with systematically different sets of demands. Methods Data were obtained at the start of the academic semester from N=189 NCAA Division-1 athletes from a wide range of sports. The sample was 46% female. Individuals were classified as playing in a team sport (e.g., football, basketball, baseball, softball, volleyball) or an individual sport (e.g., swimming, track, golf). Sleep-related outcomes included self-reported sleep duration and sleep latency, frequency of sleeping pill use (Never, Rarely, Sometimes, Often), Insomnia Severity Index score, and Fatigue Severity Scale score. Regression analyses were adjusted for age and sex. Results In adjusted analyses, team-based athletes reported 22.4 minutes less sleep than individual athletes (95%CI -42.8,-1.9; p&lt;0.05). They also reported 5.6 less minutes of sleep latency (95%CI -10.8,-0.3; p&lt;0.05). More frequent sleeping pill use was also reported (oOR=0.96; 95%CI: 0.26,1.67; p=0.007). They did not report any differences in insomnia or daytime fatigue levels. Conclusion These results suggest that even though team-based athletes may not report more sleep complaints or daytime complaints, they may be at increased risk for less sleep and more sleep medication. Further work is needed to identify the sources of these differences to guide interventions. Support The REST study was funded by an NCAA Innovations grant. Dr. Grandner is supported by R01MD011600


SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A301-A301
Author(s):  
Andrew Tubbs ◽  
Knashawn Morales ◽  
Michael Grandner ◽  
Jason Ellis ◽  
Ivan Vargas ◽  
...  

Abstract Introduction Suicide is the 10th leading cause of death among US adults, and disrupted sleep significantly increases suicide risk. It is unclear, however, how quickly changes in sleep can affect suicidal thoughts and behaviors. Therefore, the present study explored whether insomnia, sleep continuity, and nightmares predicted subsequent suicidal thinking. Methods Data were drawn from N=1,248 individuals 35 years and older who were part of a 1-year prospective study of the natural history of insomnia. Suicidal ideation was measured biweekly from the Patient Health Questionnaire – 9 and dichotomized (Score = 0, No; Score &gt; 0, Yes). The primary predictors were Insomnia Severity Index (ISI) score and total wake time, total sleep time, difficulty initiating/maintaining sleep, and nightmares (from daily sleep diaries). Predictors were averaged over the previous 2 weeks and measured 2 nights prior to measuring suicidal ideation. Data were modeled using generalized estimating equations to account for within-subject correlations and adjusted for age, sex, and race/ethnicity. Results A total of N=124 individuals (65% female) reported suicidal ideation during the study. In unadjusted models, no sleep variable was associated with subsequent suicidal ideation. However, after adjusting for age, sex, and race/ethnicity, insomnia severity was associated with subsequent suicidal ideation when averaged over the preceding 2 weeks (OR 1.09 per point on the ISI, 95% CI [1.03–1.16]) and measured 2 days prior (OR 1.11 per point on the ISI, 95% CI [1.01–1.22]). Stratified analyses showed that this effect was driven by age, with insomnia predicting suicidal ideation in individuals 55–64 and 65 and older. Conclusion Insomnia is a significant, proximal risk factor for suicidal ideation, particularly in older adults. Consequently, treatment of insomnia may represent an effective suicide risk reduction strategy. Support (if any) K24AG055602 R01AG041783


2013 ◽  
Vol 42 (2) ◽  
pp. 186-198 ◽  
Author(s):  
Markus Jansson-Fröjmark

Background: Dysfunction is an integral part of chronic insomnia. Despite this, very little effort has yet been made to design and psychometrically validate an insomnia-specific measure of dysfunction. Aims: The purpose was to examine the psychometric properties of the Work and Social Adjustment Scale (WSAS) as a measure of dysfunction in chronic insomnia. Method: Seventy-three patients with chronic insomnia from three subsamples participated. All the patients completed the WSAS, the Insomnia Severity Index (ISI), and sleep diaries over one week. Results: An exploratory factor analysis suggested a one-factor solution for the WSAS, determining dysfunction, accounting for 73.7% of the variance. The internal consistency of the WSAS was α = .91. The test-retest reliability for the WSAS items was high at .90–.99 and for the entire scale .99. A cut-off at 17 points was established, discriminating those with subclinical versus moderate or severe clinical insomnia (88% sensitivity and 78% specificity). Evidence of convergent and criterion validity was documented via (1) a significant, positive association between the WSAS and ISI and (2) a higher WSAS score among those with severe clinical insomnia, relative to those with moderate clinical and subthreshold insomnia, as well as a higher WSAS score among those with moderate clinical insomnia relative to those with subthreshold insomnia. The WSAS was also shown to be a treatment-sensitive measure for insomnia patients. Conclusions: The WSAS appears as a reliable and valid measure of dysfunction in chronic insomnia. Additional advantages are its shortness, easiness, and treatment-sensitivity.


2019 ◽  
Author(s):  
Bart Verkuil ◽  
Briana Brownlow ◽  
Michael Vasey ◽  
Jos F. Brosschot ◽  
Julian F. Thayer

Worry is a central process in a wide range of psychopathological and somatic conditions. Three studies (N = 856) were used to test whether a subscale composed of five items of the most commonly used trait anxiety questionnaire, Spielberger’s State Trait Anxiety Inventory-Trait version (STAI-T), is appropriate to measure worry. Results showed that the subscale, named the Brief Worry Scale (BWS), had excellent internal consistency and temporal stability. Convergent and divergent validity were supported by correlation analyses using worry questionnaires and measures of anxious arousal and depression. The BWS was a particularly good predictor of the pathogenic aspects of worry, including worry perseveration in daily life (study 1), measures of clinical worry (study 2) and the uncontrollability of experimentally induced worry (study 3). Taken together, these studies demonstrate that the BWS might be a valuable scale for pathological worry, for which many researchers already have data.


2021 ◽  
pp. 089033442199105
Author(s):  
Bárbara Figueiredo ◽  
Tiago Miguel Pinto ◽  
Raquel Costa

Background Exclusive breastfeeding has a wide range of benefits for maternal health. However, the benefit of exclusive breastfeeding for maternal mental health needs to be further explored. Research Aim To determine the moderating role of exclusive breastfeeding at 3 months on the association between prenatal and postpartum depression. Methods This study had a prospective, longitudinal, and comparative design with two groups and three assessment waves. The sample comprised 334 participants (70 depressed and 264 non-depressed) recruited at public health services in northern Portugal. Participants completed a measure of depression symptoms between the second and the third trimester of pregnancy and between 3 and 6 months, and a measure of breastfeeding status at 3 months. Results Exclusive breastfeeding at 3 months moderated the association between prenatal and postpartum depression. Participants with prenatal depression who were exclusively breastfeeding at 3 months showed fewer symptoms of depression and lower rates of depression between 3 and 6 months postpartum, compared to participants with prenatal depression who were not exclusively breastfeeding. Participants without prenatal depression who were exclusively breastfeeding at 3 months showed similar depression symptoms and similar rates of depression between 3 and 6 months postpartum, compared to participants without prenatal depression who were not exclusively breastfeeding. Conclusion Exclusive breastfeeding has a potential protective influence on postpartum depression among women with prenatal depression. Public health policies targeting women with prenatal depression should be implemented and include practices to promote and support exclusive breastfeeding in order to enhance women’s exclusive breastfeeding and mental health.


Sign in / Sign up

Export Citation Format

Share Document